America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. The ongoing development of new life-saving and life-improving medicines would not be possible without a robust pipeline of science, technology, engineering and math (STEM) workers at all levels.
